Brenna Marks

Brenna Marks currently serves as the Director of Radiopharmaceutical Development & Production at Perspective Therapeutics since July 2023, following a tenure as a Biomedical Engineer at Viewpoint Molecular Targeting, Inc. from October 2017 to August 2023, focusing on personalized image-guided therapy solutions for cancer patients. Brenna's early experience includes a Research Assistant Internship at Atlantis in 2018, where participation in the Atlantis International Clinical Shadowing program provided valuable clinical exposure. Academic credentials include a Bachelor of Science in Engineering with a specialization in Biomedical Engineering-Biomaterials and Biomechanics from the University of Iowa (2017-2019), along with studies at Iowa State University and Kirkwood Community College, as well as a high school diploma from Iowa City West High School (2011-2015).